MTP-101-C

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameMTP-101-C
Drug Alias NameMTP-101-C
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsAmyotrophic Lateral SclerosisLiver CirrhosisHepatic Encephalopathy +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCures Within Reach
China Registration ClassN/A

Develop Information

Active CompaniesVa Office Of Research And DevelopmentUniversity Of MinnesotaDuke University +[4] 
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisLiver CirrhosisHepatic Encephalopathy +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A